Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
ANDERSSON, BORJE S
One or more keywords matched the following items that are connected to ANDERSSON, BORJE S
Item TypeName
Academic Article Stability-indicating high-performance liquid chromatographic assay of busulfan in aqueous and plasma samples.
Academic Article 5-Aza-2'-deoxycytidine sensitizes busulfan-resistant myeloid leukemia cells by regulating expression of genes involved in cell cycle checkpoint and apoptosis.
Academic Article Synergistic cytotoxicity of the DNA alkylating agent busulfan, nucleoside analogs and suberoylanilide hydroxamic acid in lymphoma cell lines.
Academic Article Altered gene expression in busulfan-resistant human myeloid leukemia.
Academic Article Epigenetic modifiers enhance the synergistic cytotoxicity of combined nucleoside analog-DNA alkylating agents in lymphoma cell lines.
Concept Alkylating Agents
Concept Antineoplastic Agents, Alkylating
Academic Article The histone deacetylase inhibitor SAHA sensitizes acute myeloid leukemia cells to a combination of nucleoside analogs and the DNA-alkylating agent busulfan.
Academic Article Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemia.
Academic Article Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALL.
Academic Article Formulation and stability of busulfan for intravenous administration in high-dose chemotherapy.
Academic Article High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplant.
Academic Article Mechanisms of resistance to the toxicity of cyclophosphamide.
Academic Article Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survival.
Academic Article Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia.
Academic Article Pharmacokinetics and individualized dose adjustment of intravenous busulfan in children with advanced hematologic malignancies undergoing allogeneic stem cell transplantation.
Academic Article Busulfan and metronidazole: an often forgotten but significant drug interaction.
Academic Article Intravenous busulfan in pretransplant chemotherapy: bioavailability and patient benefit.
Academic Article Intravenous busulfan plus melphalan is a highly effective, well-tolerated preparative regimen for autologous stem cell transplantation in patients with advanced lymphoid malignancies.
Academic Article Clarifying busulfan metabolism and drug interactions to support new therapeutic drug monitoring strategies: a comprehensive review.
Academic Article Fludarabine-IV busulfan, dose-intensity and progression-free survival: Are we finally finding the way to reach a consensus opinion?: Higher busulfan dose intensity appears to improve leukemia-free and overall survival in AML allografted in CR2: An analysis from the acute leukemia working party of the European group for blood and marrow transplantation.
Academic Article Development of an assay for cellular efflux of pharmaceutically active agents and its relevance to understanding drug interactions.
Academic Article Epigenetic modification enhances the cytotoxicity of busulfan and4-hydroperoxycyclophosphamide in AML cells.
Academic Article Reduced intensity vs. myeloablative conditioning with fludarabine and PK-guided busulfan in allogeneic stem cell transplantation for patients with AML/MDS.
Academic Article Pharmacokinetics: Unique Challenges in Blood Monitoring for Oncology Nurses.
Academic Article ABT199/venetoclax potentiates the cytotoxicity of alkylating agents and fludarabine in acute myeloid leukemia cells.
Search Criteria
  • Alkylating Agents